跳至主要内容
临床试验/CTRI/2021/08/035578
CTRI/2021/08/035578尚未招募未知

Pharmacokinetics of first line antitubercular drugs in tuberculosis patients: A comparative study in Patients with and without concomitant Diabetes mellitus

Maulana Azad Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)Newly diagnosed pulmonary tuberculosis patients taking daily antitubercular drugs according to NTEP guidelines(2019)
  • 2)Patiients diagnosed with type 2 diabetes mellitus( on diet control or oral antidiabetic drugs or fasting BG >126mg/dl or postprandial BG >200 mg/dl or random BG >200mg/dl or HbA1c >6.5%
  • 3) Sensitive to rifampicin detectced by cartridge based nucleic acid amplification test(CBNAAT)

排除标准

  • Patients with
  • 1)Abnormal liver function tests(AST or ALT or both >50 IU)
  • 2) Abnormal renal function tests( Creatinine >1.5mg/dl and urea >40 mg/dl)
  • 3) Pregnant and nursing mothers
  • 4) On concomitant Anti retroviral treatment
  • 5) On immunosuppressive medication
  • 6) On corticosteroid therapy
  • 7) Body weight less than 30kg
  • 8)sick or moribund patients
  • 9)Patients developing severe adverse drug reactions during treatment

研究者

相似试验